Search results
Hyundai Motor, Suppliers Shares Rise in Seoul as India Unit Files for IPO
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Plans for what may be one of India’s largest-ever initial public offerings boosted...
QuantumPharm becomes Hong Kong's third-largest IPO of 2024 after pricing shares at HK$5.28
South China Morning Post via Yahoo Finance· 6 days agoTencent-backed QuantumPharm, an artificial intelligence (AI) drug researcher, has become Hong Kong's...
TEM Stock IPO: 7 Things to Know as Tempus AI Starts Trading Today
InvestorPlace· 3 days agoOne of the season’s most highly anticipated initial public offerings (IPOs) is taking place today....
IPO Preparedness: Hear from ICR President Don Duffy at Nasdaq
IPO-Edge.com via Yahoo Finance· 4 days agoIPO Edge hosted a fireside chat at the Nasdaq MarketSite with Don Duffy, President at ICR. The...
Tempus AI IPO Opens Higher by 8% By Investing.com
Investing.com· 3 days agoAll of the shares of Class A common stock are being offered by Tempus. The gross proceeds to Tempus from the offering, before deducting underwriting...
Special Opportunities REIT: London's biggest IPO of 2024 falls through in fresh blow to City
Evening Standard via Yahoo Finance· 5 days agoAn IPO that would have been London’s biggest of 2024 fell through today, as Special Opportunities...
Factbox-IPO-bound Hyundai India and its rivals in the world's third-biggest car market
Reuters via Yahoo Finance· 2 days agoHyundai Motor India sought regulatory approval on Saturday to list on the Mumbai stock market in...
Hyundai Motor India plans record-breaking $3 billion IPO
Investing.com· 3 days agoThe targeted valuation for the IPO is between $18 billion and $20 billion, which could make it the...
Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with...
TechCrunch· 2 days agoTempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously...
Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
FierceBiotech· 7 days agoSpecifically, Alumis plans to use part of the IPO haul to advance the development of its lead asset,...